health
Veterinary medicinal cannabis market projects 35% growth in 2026: benefits driving consumption
Medicinal cannabis for pets. Photo: Private Archive
TL;DR
- Veterinary medicinal cannabis is emerging as a therapeutic solution for pets in Colombia, addressing chronic pain, anxiety, skin sensitivities, and mobility issues.
- The market is projected to grow by 35% in Colombia by 2026, driven by the adoption of alternative therapies and a supportive regulatory framework.
- Certified cannabis medicine for animals, primarily using CBD, is designed specifically for different species and reacts positively with their natural endocannabinoid system.
- CBD-based treatments do not sedate pets and are effective for geriatric patients with osteoarthritis, animals with anxiety and stress, refractory epilepsy, and dermatological/inflammatory conditions.
- Colombia's regulatory standards ensure safe, contaminant-free products with exact concentrations, positioning the country as a regional leader in cannabinoid science for fauna.
- Veterinary supervision is essential for initiating CBD treatments to adjust dosage, avoid accidental intoxication, and ensure it complements existing treatments.